chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Per Staff - VARES 12:02 pm 11.06.2023 via phone  ** Warning: Knowingly filing a false VAERS report with the intent to mislead the Department of Health and Human Services is a violation of Federal law (18 Code § 1001) punishable by fine and imprisonment.  Practice Manager Although the employee did NOT have an adverse reaction (listed on the web site - PDF file for "adverse reaction(s)" the following form is to be completed.  The vaccine is intended to be administered to patients age 65 and above. The patient DID not experience any side effects, other than tenderness (next day) at the site location left deltoid
kind of itchy and red; I think I have an allergy; Rash in my neck; kind of itchy and red; This is a spontaneous report from a contactable consumer (patient).  A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW0191; Expiration Date: 30Sep2021), dose 1 via an unspecified route of administration on 21Aug2021 as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. In Aug2021, the patient experienced kind of itchy and red and i think i have an allergy, rash in my neck. The patient reported that the patient was little worried because there was the events and asked what to do. 2nd dose was scheduled on 11Sep2021. When asked permission to probe further, the consumer stated that the consumer need a help with the question regarding the current situation. Outcome of the events were unknown. Reporter seriousness for the events were unspecified.  Follow-up activities closed. No further information expected.
Was contacted by the person's daughter on 2/5/21.  Patient started vomiting 2 days after vaccination.  She aspirated and passed away 1/16/21.  Patient had history of stroke and swallowing problems.
patient started it thing really bad and it will not stop; This is a spontaneous report received from a contactable consumer (patient) reported that 19-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), first dose (lot number: Ew0151) and second dose (lot number: Er8731) both via an unspecified route of administration in right arm on unknown date in 2021 (at the age of 19 years) as a single dose for COVID-19 immunisation. The patient medical history was not reported. Patient was not pregnant at time of vaccination. Concomitant medications included fluoxetine. Patient has taken birth control medications in two weeks and has not taken any other medications in four weeks. Patient previously took lactose and had allergies. It was reported that on 22May2021, the patient started it thing really bad and it will not stop and this event resulted in Doctor or other healthcare professional office/clinic visit. Prior to vaccination the patient was not diagnosed with COVID-19 and since the vaccination the patient has not been tested for COVID-19, has not received any other vaccines within 4 weeks prior to the COVID vaccine. The outcome of the event was not recovered.  No follow-up attempts are possible. No further information is expected.
Date 03/21/2019 - Headache and extreme fatigue. So extreme that I had no strength at all. It was like my muscles had failed to exist. At about noon I slept for approx. an hour and when I woke up it was a lot better but did not totally feel right until around 6 pm on the same day.
Site: Bruising at Injection Site-Mild, Site: Itching at Injection Site-Mild, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Additional Details: Patient has what is believed to be "COVID-arm" based on her symptoms and its appearance.  She has been using an anti-inflammatory and antihistamine to bring down the swelling and itching.  The arm had a red,itchy rash and there was some bruising.  Patient said it was also warm to touch.  She said it was more of a nuisance.
Patient complained of pain when the flu shot was injected, no complaints when 2nd vaccine (PNEUMOVAX) was administered in the same arm on 11/3. The arm started to burn and swell overnight, fever. Large area infection on right arm inside and outside the skin, now spreading down to arm and back and heavily swollen/painful throughout.
This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Horrendous pain the left arm from shoulder to tip of fingers), GAIT DISTURBANCE (Little bit unstable in walking) and VACCINATION SITE SWELLING (Swelling in the arm of injection) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure abnormal.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Mar-2021, the patient experienced PAIN IN EXTREMITY (Horrendous pain the left arm from shoulder to tip of fingers), GAIT DISTURBANCE (Little bit unstable in walking) and VACCINATION SITE SWELLING (Swelling in the arm of injection). The patient was treated with OXYCODONE at an unspecified dose and frequency. On 30-Mar-2021, PAIN IN EXTREMITY (Horrendous pain the left arm from shoulder to tip of fingers), GAIT DISTURBANCE (Little bit unstable in walking) and VACCINATION SITE SWELLING (Swelling in the arm of injection) had resolved. Not Provided          Concomitant medications reported by the patient also included pill for blood pressure and vitamin supplements.  Action taken with mRNA-1273 in response to the events was not Applicable.
Low grade fever; Aches and pains; Coughing; Trouble breathing; Wheezing; Not feeling well; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EN6203, Expiration date: unknown), dose 1 via an unspecified route of administration on 22Feb2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient stated, received Pfizer vaccine first dose yesterday (further clarified) there was supposed to be some symptoms that comes along with that like low grade fever, aches and pains, coughing (Feb2021) but actually had some trouble breathing with wheezing and coughing (Feb2021) and wanted to know if that was normal. Patient again stated that not feeling really well (Feb2021). The patient underwent lab tests and procedures which included fever: low grade on an unspecified date in Feb2021. The clinical outcome of events was unknown.  Follow-up attempts are completed. No further information is expected.
Information has been received from a 26 year old female nurse who in approximately October 2007, was vaccinated with her first dose of Gardasil. Concomitant therapy included hormonal contraceptives (unspecified). In approximately October 2007, the patient experienced injection site pain, tingling on her breast on the same side where she received the vaccination all the way to her hip right after receiving the injection. Later that same afternoon, she became nauseous. The patient recovered from the injection site pain, tingling on her breast down to her hip and nausea the next day. Additional information has been requested.
My rash cleared up in  week; This spontaneous case was reported by a consumer and describes the occurrence of RASH (My rash cleared up in  week) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (My rash cleared up in  week). At the time of the report, RASH (My rash cleared up in  week) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant products and Treatment medication were reported. No treatment medication was reported by reporter.
A questionable rash s/p immunization within 24 hours, mild swelling of her toes, fingers, and hands with erythema. No fever, no local site reaction; no vomiting. Questions being stung by an insect on the left 2nd great toes. Meds yesterday, Tylenol.
I continue to experience 'brain zaps' I've read it is common with coming off anti-depressants, which I am not nor do I abuse/use anti anxiety or MDMA. It was so sever I went to the ER. I CT brain scan was performed with negative results. The other adverse effect is massive pain to my left knee that suffers from arthritis. I received a shot of cortisone 3 weeks before my first dose in the joint and was pain free until 8 hours after my second dose. The pain is still present.
L UPPER BACK SIDE OF ARM WITH RED, RAISED AREA 45 MM X 35 MM NOTED BY GRABMOTHER THE MORNING PAST INJECTION. PATIENT C/O TNEDERNESS @ SITE
The day of getting the vaccine on 9/17/2021 (second dose) I began to have a upset stomach with diarrhea, extreme soreness in my arm and in my armpit.  This continued until I began to have severe pain on 10/2/2021, where I was hospitalized for a partial obstruction with a flare up from Crohns.  Upon presenting to the hospital my WBC was around 15 and when I left it was 17 or 18 at discharge.  I had been in remission from any symptoms of Crohns for the past 10 years.   I am still being treating with large doses of oral steroids currently which will last for the next four weeks or so and will need to follow up with doctors.
I got the vaccine, and my baby developed a full body rash, had congestion, fever, and mild retractions.
On 12/20/2022, I woke up feeling off. I thought maybe it was a seasonal bug, but then it got worse. I was feeling warm, lethargic, had a dry cough, felt fatigued, had a headache and chills. I tested myself twice for Covid-19 on 12/21/2022 and the test came back positive. I contacted my PCP. I had an appointment later that day and while there, I told them I tested positive twice and she prescribed me Paxlovid and a Z-Pack because I have a history of Pneumonia. After taking the Paxlovid, I feel that it really helped.
The child received the vaccines on 4/13/00 at a clinic. On 4/21/00 the child developed a fever of 103 - 104. The child was given Tylenol and Motrin. The fever broke on 4/23/00. Rash on trunk and arms developed on 4/24/00. Blotchy rash with papules (not chicken pox).
Started seeing spots, combination heart racing, numb finger, "blacking out aware but not aware" until she blacked out
Information has been received from a registered nurse referring to an unspecified number of patients of unknown age and gender. The patients were vaccinated with doses of improperly stored M-M-R II (lot # K024035, expiration date: 26-NOV-2016; lot# K024036, expiration date: 26-NOV-2016, route and dose were unknown) between 15-JUN-2015 and 24-SEP-2015. No adverse effected were reported. This is one of several reports received from the same reporter. Additional information has been requested.
COVID 19; COVID 19; This is a spontaneous report received from contactable reporter(s) (Physician). The reporter is the patient.  An 87-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 22Sep2022 at 11:30 as dose 5 (booster), single (Lot number: GJ2524) at the age of 87 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 31Dec2020 at 11:30 as dose 1, single (Lot number: EL3246), in left arm, on 21Jan2021 at 09:00 as dose 2, single (Lot number: FL9261), in left arm, on 28Feb2022 at 13:30 as dose 3 (booster), single (Lot number: FE3590), in left arm and on 09Apr2022 at 12:30 as dose 4 (booster), single (Lot number: FJ4989), in right arm for covid-19 immunisation. The patient's relevant medical history included: "Episodic atrial fibrillation" (unspecified if ongoing), notes: other medical history: Episodic atrial fibrillation; "post TAVR aortic valve replacement", start date: Sep2021 (unspecified if ongoing), notes: other medical history: Status post TAVR aortic valve replacement, Sep2021. The patient has no known allergies. Concomitant medication(s) included: CRESTOR, start date: 08May2007; CITALOPRAM, start date: 09Jun1992; PROSCAR, start date: 18Aug1987. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: Blood electrolytes: Normal; Blood pressure measurement: 89/42; Glomerular filtration rate: GFR was low ar 49.; Myocardial necrosis marker: Normal. Therapeutic measures were taken (PAXLOVID) as a result of drug ineffective, covid-19.; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect products to the reported events Drug ineffective and COVID-19 cannot be ruled out, based on the limited information currently available.
This spontaneous report as received from a healthcare professional refers to an unspecified number of patients. In approximately 2015 (reported as since 13-MAR-2015), the patients were vaccinated with doses of GARDASIL lot # K005881, K006960 (expiration dates, dose, route and site of administrations were not reported) that were exposed to temperatures outside of the recommended range. No adverse effects had been observed or reported. Follow up information was received from a Medical assistant on 02-JUL-2015 concerning an adult patient of unknown age and gender who on 12-MAY-2015 was vaccinated with a dose of GARDASIL lot # K006960 (exp date, dose and route of administration not provided). According to the reporter the vaccine dose administered underwent a temperature excursion for 103 hours. This is one of several reports from the same reporter. Additional information is not expected as all correspondence was received.
shingles; Products liability: manufacturing defect/defective design; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 72 years old patient of unspecified gender. No information was received regarding medical history, concurrent conditions, or concomitant medications.  On an unspecified date in 2007, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) injection (dose, strength, route and site of administration, lot# and expiration date were not reported) for the long-term prevention of shingles and zoster-related conditions. On an unspecified date, the patient was treated for the following injuries resulting from the patient's zoster vaccine live (ZOSTAVAX) use: shingles. The patient claimed damages as a result of: Injury to themselves; Loss of consortium; Loss of services; Economic losses. The following claims were asserted: negligence; products liability - defective design; products liability - manufacturing defect; products liability-failure to warn; breach of express warranty; breach of implied warranty; fraudulent misrepresentation; fraudulent concealment; negligent misrepresentation; unjust enrichment; strict liability; consumer fraud; loss of consortium; punitive damages. The outcome of the events was not provided. The causality between the event of shingles and the suspect therapy was reported as related. The causality between the product quality issue and zoster vaccine live (ZOSTAVAX) was not provided.
This case was reported by a consumer via call center representative and described the occurrence of dizziness in a adult female patient who received FLUARIX Quadrivalent. Co-suspect products included FLUARIX Quadrivalent. The patient's past medical history included Meniere's disease. On an unknown date, the patient received FLUARIX Quadrivalent 2016-2017 at an unknown dose and FLUARIX Quadrivalent 2017-2018. On an unknown date, less than a year after receiving FLUARIX Quadrivalent 2016-2017 and not applicable after receiving FLUARIX Quadrivalent 2017-2018, the patient experienced dizziness and dizziness. On an unknown date, the outcome of the dizziness was recovered/resolved and the outcome of the dizziness was unknown. It was unknown if the reporter considered the dizziness to be related to FLUARIX Quadrivalent 2016-2017. It was unknown if the reporter considered the dizziness to be related to FLUARIX Quadrivalent. Additional details were reported as follows: The age at vaccination was not reported. The patient reported that she experienced dizziness after receiving the FLUARIX vaccine this year and last year. The patient did have a history of Meniere's disease but she did not believe that was responsible for the dizziness she had experienced after the vaccinations. The patient did not want to provided any details of her experience and she refuse to provide demographic information. The patient denied permission to contact her physician.
Had pain under left arm in the armpit. Armpit has swelling and soreness, swelling is the size of a baseball.
This case was considered medically important (OMIC). Information regarding Haemophilus B conjugate vaccine was received from an attorney regarding a male pt who experienced mercury poisoning and neurodevelopmental injuries. The pt received a dose on an unspecified date. It is alleged that as a result of cumulative exposure to mercury in the thimerosal-containing vaccine (s), the child developed "severe" neurodevleopmental injuries of mercury poisoning. No additional info was available at the time of this report.
I developed a cute onset of abdominal pain on 10/31 at 2pm. I had immediate diarrhea and nausea that lasted 30 mins. Began having rectal bleeding and that persisted for several hours so I went to the ER. They checked me there and had a CT scan. Diagnosed with acute colitis. Bleeding for pretty slow at that point and they sent me home. Followed up with GI specialist he said that I had ischemic Colitis, got IV fluids at the ER and there was no other treatments. Self resolved.
She says she had an accident; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 62 years as dose 1 single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ACCIDENT (non-serious), outcome "unknown", described as "She says she had an accident".  Additional information: Caller is calling because she couldn't find the number to get this corrected on anything. She answered some questions on a survey and she had to dial in on this number to see about her appointment on the 17th which is Wednesday at 11 AM. She says she had an accident and she had to go to the orthopedic doctor and they are going to do a medicine report for her on the 17th to ensure her a different pain medication. No further information provided. She clarifies she is calling to try to change her appointment or maybe to get a later time because her appointment is at 9 o'clock but she has a pain med appointment at the orthopedic too. She says these are the only numbers that she has for the contact. So she called to let them know about the appointment and to try to get it scheduled for another time. She doesn't know how to get up with them, she asks if call handler has any kind of way to refer her back to like a back number of Pfizer. She just tried to connect to someone using questionnaire that they gave and this was the only number on the sheet they gave after she had the first shot and they scheduled her for the second shot which is the 17th she just wanted to see if she could get it at a later time in the day. Reporter details: She worked as a caretaker. She does not want any follow up. She has so many appointments and calls to set up and she talks to a lot of people. She is trying to get stuff settled with this appointment now. She declines to provide mailing address and email address. Primary Care details: Caller declines to provide. She would like to keep that private between her doctor and herself. Product details: She does not have her vaccine card with her but it was definitely Pfizer COVID 19 vaccine. They had her a questionnaire and helped her fill it out and it was Pfizer. She does not have the NDC lot expiration to provide or any dose information. She wouldn't know any of that.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient received MMR & Hib in left thigh and flu in right thigh at 12:15pm. At 4:15 pm, after waking from a nap, patient completely refused to bear weight on left leg. After administration of Motrin & warm compresses, patient would bear weight on left leg but would only toe walk with severe limp. On day #2, patient ambulated with limp. On day #3, patient began toe walking again. Toe walking was worse after waking in the morning, after sitting for extended periods, and after taking nap. Patient limped for total of 8 days but limp resolved completely by the evening of 9/23. There were no other symptoms. There was no erythema, swelling, or induration of left leg. Patient's leg had full range of motion and full strength throughout the 8 days. No fevers. Patient did not seem in pain or seem overly irritable.
A report was received from a healthcare professional on 04/Dec/2006, concerning a vaccinee (no identifiers provided). No details concerning the vaccinee past medical history or concomitant medications were provided. The vaccinee was administered Fluvirin on an unspecified date, and was subsequently diagnosed as having brachial neuritis. Follow up information was received from a health care professional on 05/Dec/2006. the vaccinee has been identified as a 33 year old, who received 0.5ml of Fluvirin by intramuscular injection. The vaccinee has still not recovered. The reporter considered the event to be serious, hospitalisation and disability/incapacity. Further information will be requested.
Induration 5.5 x 4.5cm, redness 7.5 cm.
Unusual lump on left leg and refusal to mear weight 10/31/2001 AM onset transfer to ER where increased WBC greater than 24,000 and CRP equals 3.2; negative X-ray. Resolved in a few days. Repeat WBC.
Pt felt a chest and stomach burning about 10 minutes, throat tightness, and tingling around her mouth
First 36 hours after injection had injection site swelling and pain, and exhaustion.  Starting 21April2021 Sinus Congestion, running nose, headache, sore throat.
pt recv vax 22OCT96 & 23OCT96;pt devel vomit & diarrhea w/o fever 48hr p/vax;pharmacist related there wee other pt that exp v, d who did not recv vax;this is one of 25 cases reported by a pharmacist;
Dizziness, headache, nausea, vomiting, ringing in ears.
Hospitalization due to COVID 19 Reported per Moderna COVID-19 Vaccine EUA
Intussusception requiring open surgical reduction 10/16/2012 - 13 days after vaccine administration.
Developed tachycardia, tremors, hypertension, rash. Given diphenhydramine and fluid bolus in ED and discharged home.
Patient's mother states her son experienced  hives on his  right side of his forearm. She states the hives were huge in size also that he also had diarrhea 24 hours after his vaccine. He was taken to the ER to get checked out. At the ER they told her that maybe a bee sting him or it was because of the vaccine. His right hand and forearm were swollen.  The hives lasted a few hours then it went away. He was given Benadryl for 5 days straight at the ER which helped to decrease his symptoms.  His mother states he is no longer having the hives or diarrhea.